Product Description

Ventipulmin Solution for Injection is indicated for the management of respiratory disease in horses where airway obstruction is considered a contributing factor. It may be used as a standalone treatment or as part of adjuvant therapy. In cases accompanied by bacterial infection, the administration of appropriate antimicrobial agents is recommended alongside treatment.

For Horses:

Management of acute, sub-acute and chronic respiratory allergies where bronchospasm or airway obstruction is a contributing factor

Management of acute, sub-acute and chronic respiratory infections — including bronchitis, bronchiolitis, and bronchopneumonia — where the presence of mucus and/or micro-organisms stimulates bronchospasm or causes airway obstruction and increased airway resistance; conditions may include those associated with equine influenza and other viral respiratory diseases

Management of Chronic Obstructive Pulmonary Disease (COPD) / recurrent airway obstruction where bronchospasm and mucus accumulation are contributing factors

Which Animals Can Use Ventipulmin Solution for Injection?

Ventipulmin Solution for Injection is licensed for use in horses only. It must not be used in horses with known cardiac disease, or in animals with a known hypersensitivity to clenbuterol hydrochloride. It must not be used in animals producing milk for human consumption. This product is for intravenous use only and must be administered by or under the supervision of a veterinary surgeon. Always use only under the direction of your vet, and ensure a valid prescription is in place before ordering.

Available Strengths & Sizes

Please order the specific pack size as directed on your veterinary prescription. Ventipulmin Solution for Injection is available in a single strength of 30 micrograms clenbuterol hydrochloride per ml.

Directions for Use

This is a prescription medication and must be used exactly as directed by your veterinary surgeon. The product is administered by slow intravenous injection; dosage depends on the horse's body weight. Treatment should continue for as long as directed by the prescribing veterinary surgeon. Avoid introduction of contamination during use. Refer to the dispensing label or product datasheet for full dosing instructions. Do not exceed the prescribed dose.

Contraindications

Source: SPC Sections 4.3 & 4.4

Do not use in horses with known cardiac disease

Do not use in cases of known hypersensitivity to clenbuterol hydrochloride

Do not use in animals producing milk for human consumption

If used during pregnancy, treatment must be discontinued at the expected time of delivery, as uterine contractions may be abolished under the influence of this product

Storage & Handling

Do not store above 25°C. Protect from light. Should any growth or discolouration occur in the solution, the product must be discarded. Keep out of the sight and reach of children and animals at all times. Following withdrawal of the first dose, use the product within 28 days; discard any unused material. Shelf life of the product as packaged for sale: 3 years.

Withdrawal period:

Horses — meat and offal: 28 days

Not authorised for use in animals producing milk for human consumption

Important Warnings

Source: SPC Section 4.5

Following intravenous administration, transient mild muscle tremor and sweating may occur; these effects are associated with peripheral vasodilation, a feature of all beta-adrenergic drugs, and may be minimised by administering the product slowly

This product antagonises the effects of prostaglandin F2-alpha and oxytocin; do not use concurrently where these effects are required

This product is antagonised by beta-adrenergic blocking agents; in cases of accidental overdose, a beta-blocker such as propranolol may be used as an antidote under veterinary supervision

In cases of respiratory disease complicated by bacterial infection, concurrent administration of appropriate antimicrobial agents is recommended

Human safety — accidental self-injection: Accidental self-injection may produce tachycardia and tremor; these effects may be reversed by the use of a non-selective beta-blocker. If accidental self-injection occurs, seek medical advice immediately, avoiding driving if possible

Human safety — clenbuterol (beta-agonist): This product contains clenbuterol, a beta-agonist. Avoid skin contact when handling the product; in case of skin contact, wash the affected area thoroughly and seek medical advice if irritation occurs or persists

Human safety — eye contact: Take care to avoid accidental eye contact. In the case of accidental eye contact, flush thoroughly with clean water and seek medical advice

Human safety — general precautions: Do not eat, drink or smoke when using this product. Wash hands thoroughly after use

POM-V Prescription Notice

This product is a Prescription Only Medicine — Veterinary (POM-V). It may only be supplied by a veterinary surgeon or, when prescribed by a veterinary surgeon, by a pharmacist or SQP. A valid veterinary prescription is required before this product can be dispensed.

MA Number: Vm 08327/5067 (UK GB) | Source: VMD Product Information Database (vmd.defra.gov.uk)